Huntsman
HUN
8.63
-0.14
-1.60%
Huntsman
US · HUN
#2975 by market cap
Listed 1970
8.63
-0.14
-1.60%
Live - 5344 symbols - heartbeat 64s ago
· 2026-10-08 08:02
Pre-market
8.80
+1.97%
After-hours
8.80
+1.97%
- Market cap
- 1.51B
- P/E (TTM)i
- -8.22
- P/Bi
- 0.56
- EPSi
- -1.65
- Div yieldi
- 5.94%
- 52W posi
- 18%
Reader sentiment
Are you bullish or bearish on HUN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.47, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -5.85% YoY
Margins
- Gross margin
- 13.21%
- Operating margin
- -0.37%
- Net margin
- -5.00%
Key ratios & quality
- Enterprise valuei
- 3.15B
- Altman Z-Scorei
- 1.47
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 7.60B | 6.80B | 6.02B | 7.67B | 8.02B | 6.11B | 6.04B | 5.68B |
| Gross profit | 1.76B | 1.38B | 1.10B | 1.58B | 1.55B | 906.00M | 866.00M | 751.00M |
| Selling & admin expenses | 789.00M | 786.00M | 775.00M | 739.00M | 711.00M | 689.00M | 671.00M | 670.00M |
| Research & development | 145.00M | 137.00M | 135.00M | 135.00M | 125.00M | 115.00M | 121.00M | 120.00M |
| Operating profit | 822.00M | 428.00M | 235.00M | 743.00M | 758.00M | 102.00M | 73.00M | -21.00M |
| Pretax profit | 734.00M | 391.00M | 337.00M | 1.25B | 697.00M | 99.00M | -39.00M | -192.00M |
| Tax | 45.00M | -38.00M | 46.00M | 191.00M | 186.00M | 64.00M | 61.00M | 26.00M |
| Net profit | 650.00M | 598.00M | 1.07B | 1.10B | 523.00M | 153.00M | -127.00M | -227.00M |
| Basic EPS | 1 | 2 | 5 | 5 | 2 | 1 | -1 | -2 |
| Diluted EPS | 1.39 | 2.44 | 4.66 | 4.72 | 2.27 | 0.57 | -1.10 | -1.65 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.41B | 1.46B | 1.46B | 1.36B | 1.42B | 1.66B |
| Gross profit | 201.00M | 182.00M | 204.00M | 164.00M | 183.00M | 245.00M |
| Selling & admin expenses | 166.00M | 160.00M | 163.00M | 181.00M | 163.00M | 183.00M |
| Research & development | 32.00M | 33.00M | 29.00M | 26.00M | 29.00M | 28.00M |
| Operating profit | 10.00M | 4.00M | 18.00M | -53.00M | -10.00M | 24.00M |
| Pretax profit | 27.00M | -139.00M | -7.00M | -73.00M | -29.00M | 26.00M |
| Tax | 15.00M | 7.00M | 3.00M | 1.00M | 11.00M | 17.00M |
| Net profit | 11.00M | -145.00M | -11.00M | -82.00M | -41.00M | 7.00M |
| Basic EPS | 0 | -1 | 0 | -1 | 0 | 0 |
| Diluted EPS | -0.03 | -0.92 | -0.14 | -0.56 | -0.31 | -0.03 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.96B | 3.76B | 3.57B | 3.93B | 3.15B | 2.31B | 2.13B | 2.06B |
| Cash & ST investments | 340.00M | 525.00M | 1.59B | 1.04B | 654.00M | 540.00M | 340.00M | 429.00M |
| Inventory | 1.00B | 914.00M | 848.00M | 1.04B | 995.00M | 867.00M | 917.00M | 818.00M |
| Total assets | 7.95B | 8.32B | 8.71B | 9.39B | 8.22B | 7.25B | 7.11B | 7.02B |
| Total current liabilities | 1.61B | 2.01B | 1.98B | 2.05B | 1.70B | 1.17B | 1.57B | 1.59B |
| Short-term debt | 96.00M | 254.00M | 645.00M | 61.00M | 117.00M | 58.00M | 379.00M | 410.00M |
| Long-term debt | 2.22B | 2.18B | 1.53B | 1.54B | 1.67B | 1.68B | 1.51B | 1.66B |
| Total liabilities | 5,204,000,000.00 | 5,496,000,000.00 | 5,040,000,000.00 | 4,833,000,000.00 | 4,380,000,000.00 | 3,770,000,000.00 | 3,951,000,000.00 | 4,058,000,000.00 |
| Total equity | 2.75B | 2.82B | 3.67B | 4.56B | 3.84B | 3.48B | 3.16B | 2.96B |
| Retained earnings | 292.00M | 690.00M | 1.56B | 2.44B | 2.71B | 2.62B | 2.25B | 1.81B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.29B | 2.21B | 2.18B | 2.06B | 2.18B | 2.28B |
| Cash & ST investments | 334.00M | 399.00M | 468.00M | 429.00M | 369.00M | 346.00M |
| Inventory | 1.03B | 896.00M | 836.00M | 818.00M | 885.00M | 935.00M |
| Total assets | 7.23B | 7.15B | 7.08B | 7.02B | 7.13B | 7.19B |
| Total current liabilities | 1.54B | 1.54B | 1.60B | 1.59B | 1.72B | 1.72B |
| Short-term debt | 342.00M | 429.00M | 435.00M | 410.00M | 433.00M | 419.00M |
| Long-term debt | 1.67B | 1.66B | 1.63B | 1.66B | 1.68B | 1.72B |
| Total liabilities | 4,061,000,000.00 | 4,086,000,000.00 | 4,081,000,000.00 | 4,058,000,000.00 | 4,229,000,000.00 | 4,261,000,000.00 |
| Total equity | 3.17B | 3.06B | 3.00B | 2.96B | 2.90B | 2.93B |
| Retained earnings | 2.19B | 1.99B | 1.92B | 1.81B | 1.74B | 1.72B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.21B | 897.00M | 253.00M | 952.00M | 914.00M | 209.00M | 263.00M | 289.00M |
| Depreciation & amortization | 255.00M | 270.00M | 283.00M | 278.00M | 281.00M | 278.00M | 289.00M | 287.00M |
| Free cash flow | 956.00M | 623.00M | 4.00M | 626.00M | 642.00M | -21.00M | 79.00M | 116.00M |
| Dividends paid | -156.00M | -150.00M | -144.00M | -159.00M | -171.00M | -169.00M | -174.00M | -146.00M |
| Stock buybacks / issuance | -216.00M | -206.00M | -93.00M | -190.00M | -999.00M | -344.00M | -4.00M | 0 |
| Ending cash balance | 340.00M | 525.00M | 1.59B | 1.04B | 654.00M | 540.00M | 340.00M | 429.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -74.00M | 91.00M | 196.00M | 76.00M | -53.00M | -60.00M |
| Depreciation & amortization | 69.00M | 72.00M | 73.00M | 73.00M | 73.00M | 77.00M |
| Free cash flow | -110.00M | 54.00M | 153.00M | 19.00M | -91.00M | -90.00M |
| Dividends paid | -44.00M | -43.00M | -44.00M | -15.00M | -16.00M | -16.00M |
| Stock buybacks / issuance | -- | -- | -- | 0 | -- | -- |
| Ending cash balance | 334.00M | 399.00M | 468.00M | 429.00M | 369.00M | 346.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.11 | 21.59 | 33.32 | 26.47 | 11.50 | 2.94 | -6.09 | -9.95 |
| ROA %i | 3.70 | 6.91 | 12.14 | 11.54 | 5.22 | 1.31 | -2.63 | -4.02 |
| ROIC %i | 8.82 | 12.44 | 19.02 | 17.69 | 8.35 | 2.75 | -2.41 | -4.28 |
| 5-year avg ROE %i | 18.51 | 19.38 | 24.89 | 25.41 | 21.20 | 19.16 | 13.63 | 4.97 |
| EBIT margin %i | 11.27 | 7.39 | 7.03 | 16.33 | 9.46 | 2.68 | 0.66 | -1.99 |
| FCF / sales %i | 9.53 | 9.17 | 0.07 | 7.22 | 8.00 | -- | 1.31 | 2.04 |
| Current ratioi | 1.84 | 1.87 | 1.80 | 1.92 | 1.85 | 1.97 | 1.36 | 1.30 |
| Quick ratioi | 0.95 | 0.74 | 1.26 | 1.16 | 0.87 | 1.10 | 0.68 | 0.70 |
| Debt / assetsi | 29.17 | 33.83 | 29.66 | 20.71 | 25.84 | 28.53 | 31.45 | 34.23 |
| LT debt / equityi | 88.25 | 95.31 | 55.10 | 43.03 | 55.38 | 61.83 | 62.79 | 72.40 |
| Interest coveragei | 9.19 | 4.52 | 4.92 | 20.60 | 12.24 | 2.52 | 0.51 | -1.43 |
| Revenue CAGR (3Y) %i | -2.24 | -3.30 | -4.20 | 0.29 | 5.68 | 0.51 | -7.68 | -10.86 |
| Net income CAGR (3Y) %i | 53.60 | 19.91 | 17.59 | 45.82 | -6.46 | -53.95 | -- | -- |
| FCF CAGR (3Y) %i | 103.17 | -6.82 | -84.05 | -13.16 | 1.01 | -- | -49.84 | -43.47 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -5.15 | -11.34 | -11.19 | -9.95 | -11.79 | -6.52 |
| ROA %i | -2.12 | -4.66 | -4.56 | -4.02 | -4.62 | -2.51 |
| ROIC %i | -1.73 | -5.11 | -5.05 | -4.28 | -5.41 | -2.49 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.72 | -1.35 | -2.09 | -1.99 | -2.93 | 0.00 |
| FCF / sales %i | 1.27 | 2.29 | 3.44 | 2.04 | 2.37 | -- |
| Current ratioi | 1.48 | 1.43 | 1.36 | 1.30 | 1.27 | 1.33 |
| Quick ratioi | 0.73 | 0.78 | 0.77 | 0.70 | 0.67 | 0.71 |
| Debt / assetsi | 32.56 | 34.08 | 33.90 | 34.23 | 34.88 | 34.78 |
| LT debt / equityi | 68.21 | 70.97 | 71.08 | 72.40 | 76.61 | 77.34 |
| Interest coveragei | 1.30 | -0.99 | -1.53 | -1.43 | -2.06 | 0.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Polyurethanes is the largest reported line at 64.42% of revenue, across 3 reported segments.
- Advanced materials follows at 18.69%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Polyurethanes64.42%
Advanced materials18.69%
Performance products16.90%
Quote time 2026-10-08 08:02:00 · For reference only, not investment advice and not tailored to your situation.